arrow
返回
B

Benjamin L. Lampson

Harvard University

19H指数
71论文数
1.6K被引数
收录论文 13
发表时间
Patient-Reported Burden of Indolent Systemic Mastocytosis in a Managed Care Organization在管理式医疗组织中,患者报告的惰性系统性肥大细胞增多症的负担
err2025-01-01
err1
errOAAI
errZeiger, Robert S.; Tse, Kevin Y.; Li, Qiaowu; Saparudin, Mary; Al-Salman, Sahar S.; Puttock, Eric J.; Miller, Kerri; Powell, Dakota; Lampson, Benjamin.; Sullivan, Erin; Chen, Wansu
err分享
err收藏
Targeting oncoproteins with a positive selection assay for protein degraders用蛋白质降解物的阳性选择试验靶向癌蛋白
err2021-02-05
err29
errOAAI
errKoduri, Vidyasagar; Duplaquet, Leslie; Lampson, Benjamin L.; Wang, Adam C.; Sabet, Amin H.; Ishoey, Mette; Paulk, Joshiawa; Teng, Mingxing; Harris, Isaac S.; Endress, Jennifer E.; Liu, Xiaoxi; Dasilva, Ethan; Paulo, Joao A.; Briggs, Kimberly J.; Doench, John G.; Ott, Christopher J.; Zhang, Tinghu; Donovan, Katherine A.; Fischer, Eric S.; Gygi, Steven P.; Gray, Nathanael S.; Bradner, James; Medin, Jeffrey A.; Buhrlage, Sara J.; Oser, Matthew G.; Kaelin, William G., Jr.
err分享
err收藏
Mutant p53 induces a hypoxia transcriptional program in gastric and esophageal adenocarcinoma
err2019-08-08
err23
errOAAI
errSethi, Nilay; Kikuchi, Osamu; McFarland, James; Zhang, Yanxi; Chung, Max; Kafker, Nicholas; Islam, Mirazul; Lampson, Benjamin; Chakraborty, Abhishek; Kaelin, William G., Jr.; Bass, Adam J.
err分享
err收藏
Efficacy results of a phase 2 trial of first-line idelalisib plus ofatumumab in chronic lymphocytic leukemia
err2019-04-09
err25
errOAAI
errLampson, Benjamin L.; Kim, Haesook T.; Davids, Matthew S.; Abramson, Jeremy S.; Freedman, Arnold S.; Jacobson, Caron A.; Armand, Philippe A.; Joyce, Robin M.; Arnason, Jon E.; Rassenti, Laura Z.; Kipps, Thomas J.; Fein, Joshua; Fernandes, Stacey M.; Hanna, John R.; Fisher, David C.; Brown, Jennifer R.
err分享
err收藏
Tip of the Tongue
err2016-09-01
err0
PREAI
errLampson, Benjamin L.; Gray, Stacy W.; Cibas, Edmund S.; Levy, Bruce D.; Loscalzo, Joseph
err分享
err收藏
Activity of erlotinib when dosed below the maximum tolerated dose for EGFR-mutant lung cancer: Implications for targeted therapy development
errCANCER
IF5.1
err2016-08-15
err17
errOAAI
errLampson, Benjamin L.; Nishino, Mizuki; Dahlberg, Suzanne E.; Paul, Danie; Santos, Abigail A.; Jaenne, Pasi A.; Oxnard, Geoffrey R.
err分享
err收藏
KRAS: The Rarefied Ras Oncogene
err2015-02-05
err0
PREAI
errPershing, Nicole L.; Lampson, Benjamin; Counter, Christopher
err分享
err收藏
Rare codons capacitate Kras-driven de novo tumorigenesis
err2014-12-01
err77
errOAAI
errPershing, Nicole L. K.; Lampson, Benjamin L.; Belsky, Jason A.; Kaltenbrun, Erin; MacAlpine, David M.; Counter, Christopher M.
err分享
err收藏
Rare Codons Regulate KRas Oncogenesis
err2013-01-01
err148
errOAAI
errLampson, Benjamin L.; Pershing, Nicole L. K.; Prinz, Joseph A.; Lacsina, Joshua R.; Marzluff, William F.; Nicchitta, Christopher V.; MacAlpine, David M.; Counter, Christopher M.
err分享
err收藏
Targeting eNOS in Pancreatic Cancer
err2012-08-30
err65
errOAAI
errLampson, Benjamin L.; Kendall, S. DiSean; Ancrile, Brooke B.; Morrison, Meghan M.; Shealy, Michael J.; Barrientos, Katharine S.; Crowe, Matthew S.; Kashatus, David F.; White, Rebekah R.; Gurley, Susan B.; Cardona, Diana M.; Counter, Christopher M.
err分享
err收藏
eNOS as a therapeutic target in pancreatic cancer
err2011-04-01
err0
PREAI
errBarrientos, Katharine S.; Lampson, Benjamin L.; Kendall, Stephan D.; Counters, Christopher M.
err分享
err收藏
Untitled
err2007-11-01
err0
errOAAI
errLampson, Benjamin
err分享
err收藏